H. Eric Bjerkholt's most recent trade in Mirum Pharmaceuticals Inc was a trade of 8,000 Common Stock done . Disclosure was reported to the exchange on Aug. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 11 Aug 2025 | 8,000 | 28,236 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 2,954 | 29,046 | - | - | Employee Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.49 per share. | 11 Aug 2025 | 2,954 | 31,190 (0%) | 0% | 26.5 | 78,251 | Common Stock |
| Metagenomi Inc. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 8,572 | 8,572 | - | - | Stock Option (Right to Buy) | |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 222,133 (0%) | 0% | 0 | Common Stock | |
| Surrozen Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 1,333 | 1,333 | - | - | Option (right to buy) | |
| Metagenomi Inc. | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 42,000 | 42,000 | - | - | Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 2,667 | 35,946 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 2,667 | 5,333 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Cerus Corp | Eric H. Bjerkholt | Director | Sale of securities on an exchange or to another person at price $ 1.78 per share. | 12 Dec 2024 | 20,000 | 162,133 (0%) | 0% | 1.8 | 35,700 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 08 Nov 2024 | 475 | 33,279 (0%) | 0% | 21.0 | 9,997 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 18,334 | 32,804 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 18,334 | 36,666 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 05 Jun 2024 | 40,000 | 182,133 (0%) | 0% | 5 | 200,000 | Common Stock |
| Surrozen Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,333 | 1,333 | - | - | Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 21.05 per share. | 10 May 2024 | 470 | 14,470 (0%) | 0% | 21.0 | 9,892 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 10,000 | 10,000 | - | - | Director Stock Option (Right to Buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 24.80 per share. | 27 Mar 2024 | 2,000 | 14,000 (0%) | 0% | 24.8 | 49,600 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 25.80 per share. | 18 Mar 2024 | 2,000 | 12,000 (0%) | 0% | 25.8 | 51,600 | Common Stock |
| Mirum Pharmaceuticals Inc | H. Bjerkholt Eric | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 8,000 | 8,000 | - | - | Restricted Stock Units | |
| Cerus Corp | H. Eric Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 13 Dec 2023 | 10,000 | 142,133 (0%) | 0% | 1.6 | 16,200 | Common Stock |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2023 | 55,000 | 55,000 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Eric H. Bjerkholt | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 29.65 per share. | 11 Sep 2023 | 10,000 | 10,000 (0%) | 0% | 29.6 | 296,492 | Common Stock |
| Cerus Corp | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 21 Aug 2023 | 10,000 | 132,133 (0%) | 0% | 1.7 | 17,151 | Common Stock |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 07 Jun 2023 | 40,000 | 122,133 (0%) | 0% | 5 | 200,000 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 30 May 2023 | 150 | 3,684 | - | 4.2 | 630 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 4.09 per share. | 30 May 2023 | 100 | 3,534 | - | 4.1 | 409 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 3.20 per share. | 30 May 2023 | 5 | 3,434 | - | 3.2 | 16 | Common Stock |
| Cerus Corp | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 23 May 2023 | 5,000 | 82,133 (0%) | 0% | 2 | 10,000 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 3.27 per share. | 23 May 2023 | 500 | 3,429 | - | 3.3 | 1,634 | Common Stock |
| Surrozen Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 20,000 | 20,000 | - | - | Option (right to buy) | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 18 May 2023 | 199 | 2,929 | - | 2.6 | 527 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 3.00 per share. | 18 May 2023 | 1 | 2,730 | - | 3 | 3 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 16 May 2023 | 800 | 2,229 | - | 2.7 | 2,160 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 16 May 2023 | 300 | 2,729 | - | 2.7 | 810 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Purchase of securities on an exchange or from another person at price $ 2.67 per share. | 16 May 2023 | 200 | 2,429 | - | 2.7 | 534 | Common Stock |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2023 | 20,000 | 20,000 | - | - | Director Stock Option (Right to Buy) | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 1,429 | - | - | Common Stock | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 1,429 | 0 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 39,866 | 39,866 | - | - | Option (Right to Buy) | |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 20,454 | 77,133 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 29,983 | 29,983 | - | - | Option (Right to Buy) | |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 14,888 | 56,679 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 13,228 | 41,791 (0%) | 0% | - | Common Stock | |
| Cerus Corp | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 13,228 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 4,281 | 28,563 (0%) | 0% | - | Common Stock | |
| Cerus Corp | Eric H. Bjerkholt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2020 | 4,281 | 4,281 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) |